Latest News and Press Releases
Want to stay updated on the latest news?
-
LOS ANGELES, Jan. 16, 2026 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Vistagen Therapeutics, Inc., (“Vistagen” or the "Company") (NASDAQ: VTGN) investors off a class action on behalf of...
-
Vistagen Therapeutics Shareholder Lawsuit Filed - Contact Bernstein Liebhard For More Information
-
the Company is providing the following administrative updates to ensure it remains compliant with relevant securities regulations.
-
HINGHAM, Mass., Jan. 16, 2026 (GLOBE NEWSWIRE) -- HINGHAM INSTITUTION FOR SAVINGS (NASDAQ: HIFS), Hingham, Massachusetts announced earnings for the fourth quarter and the year ended December 31,...
-
NEW YORK, Jan. 16, 2026 (GLOBE NEWSWIRE) -- Value Line, Inc. (NASDAQ: VALU) announced today that its Board of Directors declared on January 16, 2026 a quarterly cash dividend of $0.325 per common...
-
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered In Vistagen To Contact Him Directly To Discuss Their Options If you purchased or acquired...
-
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Jayud (JYD) To Contact Him Directly To Discuss Their Options If you purchased or acquired...
-
HOUSTON, Jan. 16, 2026 (GLOBE NEWSWIRE) -- Dr. Michael Lebow, a nationally recognized board-certified vascular surgeon, announces the launch of the Dr. Michael Lebow Healthcare Made-Easy Grant, a...
-
NEW YORK, Jan. 16, 2026 (GLOBE NEWSWIRE) -- Gainey McKenna & Egleston announces that a securities class action lawsuit has been filed in the United States District Court for the Northern...
-
LOS ANGELES, Jan. 16, 2026 (GLOBE NEWSWIRE) -- Glancy Prongay & Murray LLP reminds investors of the upcoming January 20, 2026 deadline to file a lead plaintiff motion in the class action filed...